These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1253 related articles for article (PubMed ID: 3806589)

  • 1. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
    Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
    J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias.
    Showalter HD; Angelo MM; Berman EM; Kanter GD; Ortwine DF; Ross-Kesten SG; Sercel AD; Turner WR; Werbel LM; Worth DF
    J Med Chem; 1988 Aug; 31(8):1527-39. PubMed ID: 3397990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
    Leopold WR; Nelson JM; Plowman J; Jackson RC
    Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.
    Cholody WM; Martelli S; Konopa J
    J Med Chem; 1992 Jan; 35(2):378-82. PubMed ID: 1732555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, biochemical pharmacology, electrochemistry and tumour biology of anti-tumour anthrapyrazoles.
    Showalter HD; Fry DW; Leopold WR; Lown JW; Plambeck JA; Reszka K
    Anticancer Drug Des; 1986 Apr; 1(2):73-85. PubMed ID: 2453196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).
    Roberts BJ; Hamelehle KL; Sebolt JS; Leopold WR
    Cancer Chemother Pharmacol; 1986; 16(2):95-101. PubMed ID: 3081269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation.
    Stefańska B; Dzieduszycka M; Martelli S; Tarasiuk J; Bontemps-Gracz M; Borowski E
    J Med Chem; 1993 Jan; 36(1):38-41. PubMed ID: 8421288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.
    Zee-Cheng RK; Cheng CC
    J Pharm Sci; 1982 Jun; 71(6):708-9. PubMed ID: 7097541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
    J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
    Jurd L; Narayanan VL; Paull KD
    J Med Chem; 1987 Oct; 30(10):1752-6. PubMed ID: 2821258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents.
    Capps DB; Dunbar J; Kesten SR; Shillis J; Werbel LM; Plowman J; Ward DL
    J Med Chem; 1992 Dec; 35(26):4770-8. PubMed ID: 1479579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modification study of mitoxantrone (DHAQ). Chloro-substituted mono- and bis[(aminoalkyl)amino]anthraquinones.
    Zee-Cheng RK; Mathew AE; Xu PL; Northcutt RV; Cheng CC
    J Med Chem; 1987 Sep; 30(9):1682-6. PubMed ID: 3625713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
    Murdock KC; Child RG; Fabio PF; Angier RB; Wallace RE; Durr FE; Citarella RV
    J Med Chem; 1979 Sep; 22(9):1024-30. PubMed ID: 490545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, peroxidating ability, and antineoplastic evaluation of 1-[(aminoalkyl)amino]-4-hydroxy-10-imino-9-anthracenones.
    Dzieduszycka M; Martelli S; Tarasiuk J; Paradziej-Lukowicz J; Borowski E
    J Med Chem; 1991 Feb; 34(2):541-6. PubMed ID: 1995874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
    Catsoulacos P; Camoutsis C; Wampler GL
    Oncology; 1982; 39(1):59-60. PubMed ID: 7058047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity.
    Beggiolin G; Crippa L; Menta E; Manzotti C; Cavalletti E; Pezzoni G; Torriani D; Randisi E; Cavagnoli R; Sala F; Giuliani FC; Spinelli S
    Tumori; 2001; 87(6):407-16. PubMed ID: 11989596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
    Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
    J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones as potential antileukemic agents.
    Stefanska B; Dzieduszycka M; Martelli S; Borowski E
    J Med Chem; 1989 Aug; 32(8):1724-8. PubMed ID: 2754697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.